When you want to know what to do during a DEA audit or inspection in Coral Gables, you do not have time for theory. You need a practical checklist that keeps agents focused on compliance, not on building a case. Use this guide to structure your response from the moment investigators arrive until the day you close out findings with counsel.
1. Control the first 10 minutes
How you handle the first few minutes of a DEA inspection often sets the tone for everything that follows.
When investigators arrive at your Coral Gables facility or pharmacy, they will typically present credentials and a Notice of Inspection on DEA Form 82. Before you say yes or sign anything, slow the process down.
You should:
- Verify credentials and identify the lead investigator.
- Politely move the discussion to a private office, away from staff and patients.
- Notify your compliance officer, administrator, or designated DEA point person immediately.
- Contact your outside counsel experienced in legal representation for dea matters.
If you are presented with a search warrant instead of a Form 82, your options are different and more limited. In either scenario, you should not obstruct, but you also are not required to volunteer explanations or make off‑the‑cuff statements before speaking with counsel.
2. Designate a single DEA liaison
During a DEA audit or inspection in Coral Gables, you do not want every pharmacist, nurse, or medical assistant answering detailed questions about your controlled substance program.
Pick one primary liaison in advance, typically:
- Pharmacy manager or PIC
- Practice administrator
- Compliance director or risk manager
This person should understand your written policies, inventory process, dispensing workflows, and where documents are stored. The liaison walks investigators through the facility, requests clarification when needed, and helps gather records so that patient care can continue with minimal disruption.
If you have already designated this role in policy, pull that document and have it ready. Consistency between your written protocol and your real‑world response is a credibility signal.
3. Produce a complete “DEA inspection binder”
When you think about what to do during a DEA audit or inspection in Coral Gables, assume agents will ask, “Show me your records.” They want to see whether every dose of a controlled substance is traceable.
You should maintain a centralized binder or secure electronic folder that includes:
- Current DEA registration and any state controlled substance registrations
- Biennial inventory and any additional cycle counts
- Controlled substance purchasing and receiving records
- Dispensing, administration, and wastage logs, including electronic printouts
- Power of attorney forms for ordering controlled substances
- Policies and procedures for prescribing, dispensing, diversion prevention, and incident reporting
- Training logs and competency attestations for staff who handle controlled substances
Records must be accurate, detailed, and readily retrievable for at least 2 years, in line with federal retention requirements. If you scramble to find documents, you signal that your controls may be weak, even if the underlying practices are sound.
4. Demonstrate secure storage and access controls
DEA investigators focus heavily on physical and procedural security. Under 21 CFR 1301.75, controlled substances must be stored and safeguarded in a way that reasonably prevents theft and diversion.
During an inspection in Coral Gables, you should be prepared to show:
- Locked, substantially constructed cabinets or safes for controlled substances
- Limited keys or access codes with a current, documented access list
- Segregated storage of expired, quarantined, or returned controlled medications
- Cameras in high‑risk areas and documented reviews when appropriate
If you have multiple storage locations, walk investigators through each one. Confirm that what they see matches your written policies. Any discrepancy between the paper policy and practice can be used to argue systemic noncompliance.
5. Prove your inventory matches your records
Inventory reconciliation is where many providers lose ground during a DEA audit.
You should be able to:
- Show your last biennial inventory and how it was performed
- Demonstrate how you track receipts, dispensing, administration, and wastage for each controlled substance
- Reconcile physical counts with records, including adjustments and documented explanations
If there are discrepancies, do not guess. A rushed explanation can sound like an admission. Note the issue, tell investigators you need to investigate internally, and involve counsel. Persistent or unexplained discrepancies, especially involving opioids or high‑risk medications, can escalate quickly and even support allegations of diversion.
6. Show your prescribing and dispensing safeguards
For pharmacies and prescribers, Diversion Investigators will closely examine how you prevent inappropriate opioid prescribing, prescription fraud, and doctor shopping.
You should be ready to present:
- Written policies for validating prescriptions, including when to call the prescriber
- Documentation that you routinely check PDMP data, when required by state law
- Records showing that you confirm medical necessity for suspicious or high‑dose regimens
- Procedures for handling forged prescriptions or patterns suggestive of diversion
If you already work with counsel on prescription fraud defense, coordinate with them on which cases or patterns are most likely to draw questions. DEA is not just reviewing whether a script exists, it is evaluating the judgment and process behind filling or writing it.
7. Highlight your training and role‑specific protocols
Even strong written policies will not protect you if staff cannot explain their duties.
During a DEA inspection in Coral Gables, you should be able to show that:
- Staff who handle controlled substances receive initial and ongoing training
- Training is specific to their role, for example, ordering, dispensing, administering, inventory
- Attendance and competency are documented with dates and signatures
- Policies are updated periodically to reflect DEA guidance and regulatory changes
Training gaps are a common basis for criticism and can support an argument that noncompliance was foreseeable and preventable. A clear training matrix and signed acknowledgments move this conversation in your favor.
8. Document how you handle suspected diversion and losses
DEA inspectors will want to know how you respond when something goes wrong. The issue is not just whether diversion or loss occurred, but whether you detected and reported it properly.
For Coral Gables facilities and pharmacies, this includes:
- A written incident reporting policy that covers suspected diversion, tampering, and loss
- Documentation of internal investigations and corrective actions
- Use of DEA Form 106 to report significant losses or thefts, in line with DEA guidance and your own risk thresholds
Immediate reporting of theft or significant loss via Form 106 is a legal requirement. Failure to report can be more damaging than the loss itself and may jeopardize your registration. If inspectors ask about a past incident, you should be able to show the full paper trail, from initial discovery to remediation.
9. Keep staff communications controlled and consistent
During an audit, your people want to help. Uncoached help often creates problems.
You should:
- Instruct staff to be polite and cooperative but to direct all substantive questions to the designated liaison
- Remind staff not to speculate, guess numbers, or offer personal opinions about your policies
- Avoid side conversations with investigators outside the presence of your liaison or counsel
You cannot tell staff to lie and you should not obstruct. However, you can and should structure communication so that your facility speaks with one informed voice.
A good rule: facts go to investigators, interpretations go to counsel.
10. Respond strategically to preliminary findings
If investigators identify issues during the inspection, they may discuss them before leaving or later in a written notice, such as a Letter of Admonishment or an Order to Show Cause.
You should work with experienced federal counsel to:
- Correct recordkeeping and procedural errors quickly and document those corrections
- Develop or update a corrective action plan that can be shared with DEA if appropriate
- Evaluate whether a Memorandum of Agreement is a viable resolution path
A Letter of Admonishment is a warning and often guarantees a follow‑up visit within one to two years. More serious findings can lead to an Order to Show Cause, an administrative hearing, or even emergency license suspension in collaboration with state boards. Do not negotiate alone, and never agree to voluntarily surrender your DEA registration without a complete legal risk assessment.
11. Conduct a post‑inspection self audit
Once the DEA team leaves Coral Gables, your real work begins. A disciplined debrief can prevent the next inspection from turning into an enforcement case.
After the visit, you should:
- Document exactly what investigators requested and any concerns they raised
- Close any documentation gaps, including missing signatures, outdated policies, or incomplete inventories
- Tighten high‑risk areas like opioid prescribing, destruction procedures, and after‑hours access
- Update your DEA inspection binder and staff training materials
Regular internal mock inspections, including surprise audits, help you stay ready. If you treat every month as if DEA might walk in, the actual inspection becomes a demonstration of your program instead of a stress test you are likely to fail.
5 key takeaways
- Prepare in advance. Decide who will lead, where records live, and how you will respond before DEA ever arrives in Coral Gables.
- Control the flow of information. Use a single liaison to manage questions and document requests.
- Make your records tell the story. Accurate, complete, and easily retrievable records are your best defense.
- Prove that you learn from mistakes. Thorough incident investigations, Form 106 reporting, and corrective actions carry real weight.
- Do not go through it alone. Engage The Health Law Offices of Anthony C. Vitale, P.A. or another experienced federal defense team as soon as you know DEA is involved.
FAQs about DEA audits and inspections in Coral Gables
1. How much notice will I get before a DEA inspection?
For routine audits, DEA Diversion Investigators often arrive unannounced and present DEA Form 82 at the door. You may receive advance notice in some circumstances, but you should assume you will have little or no warning. This is why keeping your inventory, records, and training up to date at all times is critical.
2. Do I have to sign DEA Form 82?
DEA Form 82 is a Notice of Inspection that you can consent to or decline. If you decline, DEA may pursue an administrative inspection warrant or search warrant depending on the circumstances. You should verify the form, contact counsel, and understand your options before signing, while avoiding any appearance of obstruction.
3. What records will DEA review during a pharmacy audit?
In a Coral Gables pharmacy audit, investigators typically review prescription records, biennial inventory, controlled substance purchase and dispensing records, and related logs. They generally do not review your financial records as part of a standard audit. They will, however, pay close attention to your opioid dispensing patterns, validation of prescriptions, and storage controls.
4. What happens if DEA finds simple recordkeeping errors?
If DEA discovers minor recordkeeping violations without evidence of diversion, the agency may issue a Letter of Admonishment. This serves as a written warning and is kept on file for future audits. It almost always results in increased scrutiny and follow‑up inspections, so you should treat it as an opportunity to overhaul your compliance program, not as a minor slap on the wrist.
5. When should I call a lawyer about a DEA audit?
You should involve experienced federal counsel as soon as you learn of an audit or inspection, and certainly before you sign Form 82, sit for interviews, or respond to any written findings. Early involvement allows counsel to shape document production, prepare staff, evaluate potential exposure, and negotiate resolutions that protect your DEA registration and professional licenses.
If you are facing a DEA audit or inspection in Coral Gables, or if you want to stress‑test your current compliance program, contact The Health Law Offices of Anthony C. Vitale, P.A. for focused, practical guidance on DEA representation and investigations.
This article is for informational purposes only and does not constitute legal advice. Accreditation requirements vary by state and payor contract.


